Drug Pipeline

L19IL2 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
1
Top Sponsors
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-03 NCT07227350
L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)		 Recruitment opened
Active Studies by Phase
Phase 2
1
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07227350 L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC) Locally Advanced Basal Cell Carcinoma Recruiting
Phase 1
NCT06640413 A Study to Evaluate the Safety and Preliminary Signs of Efficacy of [177Lu]Lu-OncoFAP-23… FAP Recruiting
NCT07566897 A Phase I Study to Evaluate the Safety and Efficacy of L19IL2 in Combination With… Renal Carcinoma Metastatic Not Yet Recruiting
Sponsors Running L19IL2 Trials
Philogen S.p.A. (3)
Get alerts when L19IL2 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free